Gilead Sciences Inc.’s shares fell after CVS Health Corp said it hasn’t yet added its new HIV prevention shot to its commercial drug plans.
www.bloomberg.com
#Gilead #Falls #CVS #Hasnt #Added #PrEP #HIV #Shot #Drug #Plans
Gilead Falls as CVS Hasn’t Yet Added PrEP HIV Shot to Drug Plans
